Sorin Crm Sas

Ela Medical S.a.s.

Ela Medical S.a.

Elodie Vincent

Marie-Anne Euzen

Marcel Limousin

Luca Vitali

Amel Amblard

Laurence Graindorge

Marie-Anen Euzen

A device produces at least two distinct temporal components (V, V) from two separate endocardial electrogram (EGM) signals concurrently collected. The capture test determines a non-temporal 2D characteristic (VGM) representative of the cardiac cycle to be analyzed. The VGM is constructed using variations of one of the temporal components (V) according to the other (V). The devices determines the presence or absence of capture by analysis of this characteristic relative to a two dimensional domain.

Active implantable medical device type such as a pacemaker with capture test by analysis of a vectogram

A device produces at least two distinct temporal components (V, V) from two separate endocardial electrogram EGM signals concurrently collected in the same cavity. A 2D non-temporal characteristic is determined from the variations of one of the temporal components (V) versus the other (V). The analysis of this characteristic allows detection of the possible presence of an anodal stimulation, causing a depolarization in a second cavity after stimulation delivered to a first heart chamber, opposite to the first. One possibility is to proceed by observing whether the non-temporal 2D characteristic is included or not within a predetermined domain defined in a coordinate frame corresponding to the space of the two temporal components.

Active implantable medical device type such as a pacemaker with detection of anodal stimulation by analysis of a vectogram

Methods, devices, and processor-readable storage media are provided for detecting spontaneous ventricular events in a heart using implantable medical devices. A method in this context includes applying a sensitivity function to collected data to detect occurrence of ventricular events. The sensitivity function is based on an adjustable detection threshold. The method further includes determining whether noise is suspected to be present in the data and, if so, increasing the threshold. The method further includes providing a stimulation pulse to the heart when a ventricular event has not occurred after a predetermined escape interval and, following the stimulation pulse, applying a capture test to detect whether an induced depolarization has occurred. If induced polarization is not detected, the threshold is reduced, while the threshold is maintained if induced polarization is detected.

Implantable defibrillator/cardioverter medical device with a dynamically adjustable threshold for ventricular detection

An active implantable medical device of the cardiac prosthesis type, including antitachycardia atrial pacing and antibradycardia ventricular pacing therapies. The device includes circuits and control logic for detecting electrical atrial and ventricular spontaneous events (R), delivering low energy antitachycardia atrial pacing, and antibradycardia ventricular pacing, and able to deliver a ventricular pacing (V) in the absence of a detected spontaneous ventricular event (R) after a calculated ventricular escape interval (IE). The device includes a sensor delivering an endocardiac acceleration signal (EA) representative of the movements produced by the contractions of the ventricle. The ventricular sensing switches from detection of an electric potential of spontaneous ventricular depolarization (R), to detection of an endocardiac acceleration peak (PEA) associated with a ventricular contraction in case of activation of the antitachycardia atrial pacing while post-atrial pacing refractory periods mask the detection of ventricular electrical activity.

Active implantable medical device having antitachycardia atrial and antibradycardia ventricular pacing

Sensing ventricular noise artifacts in an active implantable medical device for pacing, resynchronization and/or defibrillation of the heart. This device concerns sensing heart rhythm through an endocardial electrode collecting the depolarization potentials, and detecting the myocardium contractions through an endocardial acceleration sensor. The device searches for ventricular noise artifacts (X, Y) by correlating the signals representative of successive ventricular and atrial depolarizations (P, R) with the signals representative of successive acceleration peaks (PEA I). In case of a lack of correlation, a signal of suspicion of ventricular noise is delivered, which temporarily modifies the sensing sensitivity (S) of the sensing circuit.

Detecting ventricular noise artifacts in an active implantable medical device for pacing, resynchronization and/or defibrillation of the heart

Detecting a lead fracture in an active implantable medical device for pacing, resynchronization and/or defibrillation of the heart. This device senses the heart rhythm through an endocardial lead comprising at least one endocardial electrode collecting the depolarization potentials, and detecting the myocardium contractions through an endocardial acceleration sensor. The device detects an incipient or total lead fracture by correlating the signals representative of successive ventricular and/or atrial depolarizations (P, R) with the signals representative of successive acceleration peaks (e.g., PEA I). In the case of a lack of correlation, a signal of suspicion of lead fracture is delivered, notably to generate an alarm signal through recording of markers in a memory of the device readable by an external programmer, RF transmission and/or production of an audible signal.

Detecting a lead fracture in an active implantable medical device for cardiac pacing resynchronization cardioversion and/or defibrillation

An active implantable medical device for diagnosis and/or therapy that is able to detect the occurrence of apnea and hypopnea. The detection of an occurrence of respiratory apneae or hypopneae is performed by collecting the patient's endocardial acceleration (EA), and determining at least one parameter, i.e., a peak acceleration, (PEA I, PEA II) that is a function of this collected endocardial acceleration. An apnea or hypopnea alert signal is then conditionally delivered as a function of the value taken by this (these) parameter(s).

Detection of apneae and hypopneae in an active implantable medical device

A device for the non-invasive detection of apneae or hypopneae in a patient. This apparatus collects the patient's endocardial acceleration using an external acceleration sensor () able to be maintained in contact with the patient's thoracic wall (). An analysis is made to determine at least one parameter that is function of collected endocardial acceleration and to conditionally deliver an apnea or hypopnea alert signal as a function of the value taken by this parameter. This parameter can notably be a function of one and/or the other of the two endocardial acceleration peaks over one given heart cycle, the first peak (PEA I) corresponding to the ventricular isovolumetric contraction phase and the second peak (PEA II) to the ventricular isovolumetric relaxation phase.

Growing community of inventors

Antony, France

Elodie Vincent